Alcohol-chemokine interaction and neurotransmission

Neural-Immune Interactions in Brain Function and Alcohol Related Disorders

Volumn , Issue , 2013, Pages 387-424

  Gruol, Donna L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897946803     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4729-0_12     Document Type: Chapter

References (212)

1. Bennett LD, Fox JM, Signoret N (2011) Mechanisms regulating chemokine receptor activity. Immunology 134: 246-256
2. Adler MW, Geller EB, Chen X, Rogers TJ (2005) Viewing chemokines as a third major system of communication in the brain. AAPS J 7: E865-E870
3. Rostene W, Kitabgi P, Parsadaniantz SM (2007) Chemokines: a new class of neuromodulator. Nat Rev Neurosci 8: 895-903
4. Bilbo SD, Smith SH, Schwarz JM (2012) A lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia. J Neuroimmune Pharmacol 7: 24-41
5. Mines M, Ding Y, Fan GH (2007) The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies. Curr Med Chem 14: 2456-2470
6. Melik-Parsadaniantz S, Rostene W (2008) Chemokines and neuromodulation. J Neuroimmunol 198: 62-68
7. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998) Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinalfluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44: 831-835
8. Rosler A et al (1998) Time course of chemokines in the cerebrospinalfluid and serum during herpes simplex type 1 encephalitis. J Neurol Sci 157: 82-89
9. Sorensen TL et al (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103: 807-815
10. Helmy A, Carpenter KL, Menon DK, Pickard JD, Hutchinson PJ (2011) The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab 31: 658-670
11. Asensio VC, Campbell IL (1999) Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 22: 504-512
12. Mennicken F, Maki R, de Souza EB, Quirion R (1999) Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci 20: 73-78
13. Streit WJ, Mrak RE, Griffin WS (2004) Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 1: 14
14. Rahman S, Miles MF (2001) Identification of novel ethanol-sensitive genes by expression profiling. Pharmacol Ther 92: 123-134
15. Crews FT, Zou J, Qin L (2011) Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun 25(Suppl 1): S4-S12
16. Blanco AM, Guerri C (2007) Ethanol intake enhances inflammatory mediators in brain: role of glial cells and TLR4/IL-1RI receptors. Front Biosci 12: 2616-2630
17. Thibault C et al (2000) Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. Mol Pharmacol 58: 1593-1600
18. Bates ME, Bowden SC, Barry D (2002) Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol 10: 193-212
19. Matsumoto I, Alexander-Kaufman K, Iwazaki T, Kashem MA, Matsuda-Matsumoto H (2007) CNS proteomes in alcohol and drug abuse and dependence. Expert Rev Proteomics 4: 539-552
20. IUIS/WHO Subcommittee on Chemokine Nomenclature (2002) Chemokine/chemokine receptor nomenclature. J Immunol Methods 262: 1-3
21. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127
22. Marinissen MJ, Gutkind JS (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368-376
23. Luttrell LM (2006) Transmembrane signaling by G protein-coupled receptors. Methods Mol Biol 332: 3-49
24. Nishiyori A et al (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia. FEBS Lett 429: 167-172
25. Meucci O et al (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95: 14500-14505
26. Coughlan CM et al (2000) Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97: 591-600
27. Klein RS et al (1999) Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J Immunol 163: 1636-1646
28. Horuk R et al (1997) Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882-2890
29. Lavi E, Kolson DL, Ulrich AM, Fu L, Gonzalez-Scarano F (1998) Chemokine receptors in the human brain and their relationship to HIV infection. J Neurovirol 4: 301-311
30. van der Meer P et al (2000) Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain. J Neuropathol Exp Neurol 60: 25-32
31. Bajova H, Nelson TE, Gruol DL (2008) Chronic CXCL10 alters the level of activated ERK1/2 and transcriptional factors CREB and NF-k B in hippocampal neuronal cell culture. J Neuroimmunol 195: 36-46
32. Wang CX et al (2006) Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERKmediated upregulation of Bcl-2. Cell Death Differ 13: 1203-1212
33. Hetman M, Gozdz A (2004) Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 271: 2050-2055
34. Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K (1997) Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 49: 681-697
35. Mattson MP (2006) NF-kappaB in the survival and plasticity of neurons. Neurochem Res 30: 883-893
36. Araujo DM, Cotman CW (1993) Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res 600: 49-55
37. Limatola C et al (2005) Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J Neuroimmunol 166: 19-28
38. Meucci O, Fatatis A, Simen AA, Miller RJ (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA 97: 8075-8080
39. Ragozzino D et al (2006) Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J Neurosci 26: 10488-10498
40. Luo Y, Lathia J, Mughal M, Mattson MP (2008) SDF1alpha/CXCR4 signaling, via ERKs and the transcription factor Egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons. J Biol Chem 283: 24789-24800
41. Cho J, Gruol DL (2008) The chemokine CCL2 activates p38 mitogen-activated protein kinase pathway in cultured rat hippocampal cells. J Neuroimmunol 199: 94-103
42. Farina C, Aloisi F, Meinl E (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol 28: 138-145
43. Flugel A et al (2001) Neuronal MCP-1 expression in response to remote nerve injury. J Cereb Blood Flow Metab 21: 69-76
44. Suk K (2007) Microglial signal transduction as a target of alcohol action in the brain. Curr Neurovasc Res 4: 131-142
45. Allaman I, Belanger M, Magistretti PJ (2011) Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci 34: 76-87
46. Ransom B, Behar T, Nedergaard M (2003) New roles for astrocytes (stars at last). Trends Neurosci 26: 520-522
47. Halassa MM, Fellin T, Haydon PG (2007) The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 13: 54-63
48. Paolicelli RC et al (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333: 1456-1458
49. Tremblay ME et al (2011) The role of microglia in the healthy brain. J Neurosci 31: 16064-16069
50. Blasko I et al (2006) Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord 21: 9-15
51. Galimberti D et al (2006) Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63: 538-543
52. Xia MQ, Bacskai BJ, Knowles RB, Qin SX, Hyman BT (2000) Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 108: 227-235
53. Sanders VJ et al (1998) Chemokines and receptors in HIV encephalitis. AIDS 12: 1021-1026
54. Fife BT et al (2001) CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617-7624
55. Kolb SA et al (1999) Identification of a T cell chemotactic factor in the cerebrospinalfluid of HIV-1-infected individuals as interferon-gamma inducible protein. J Neuroimmunol 93: 172-181
56. Tran PB, Miller RJ (2003) Chemokine receptors: signposts to brain development and disease. Nat Rev Neurosci 4: 444-455
57. Ma Q et al (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice. Proc Natl Acad Sci USA 95: 9448-9453
58. Lu M, Grove EA, Miller RJ (2002) Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 99: 7090-7095
59. Bagri A et al (2002) The chemokine SDF1 regulates migration of dentate granule cells. Development 129: 4249-4260
60. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595-599
61. Stumm R, Hollt V (2007) CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. J Mol Endocrinol 38: 377-382
62. Su B, Pan S, He X, Li P, Liang Y (2012) Sprouting of nervousfibers and upregulation of C-X-C chemokine receptor type 4 expression in hippocampal formation of rats with enhanced spatial learning and memory. Anat Rec (Hoboken) 295: 121-126
63. Parachikova A, Cotman CW (2007) Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease. Neurobiol Dis 28: 143-153
64. Rogers JT et al (2011) CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci 31: 16241-16250
65. Neves G, Cooke SF, Bliss TV (2008) Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci 9: 65-75
66. Maggi L et al (2011) CX(3)CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment. Front Cell Neurosci 5: 22
67. Ryabinin AE (1998) Role of hippocampus in alcohol-induced memory impairment: implications from behavioral and immediate early gene studies. Psychopharmacology (Berl) 139: 34-43
68. Akhondzadeh S (1999) Hippocampal synaptic plasticity and cognition. J Clin Pharm Ther 24: 241-248
69. Battaglia FP, Benchenane K, Sirota A, Pennartz CM, Wiener SI (2011) The hippocampus: hub of brain network communication for memory. Trends Cogn Sci 15: 310-318
70. Wang SH, Morris RG (2010) Hippocampal-neocortical interactions in memory formation, consolidation, and reconsolidation. Annu Rev Psychol 61: 49-79, C1-4
71. O'Reilly RC, Bhattacharyya R, Howard MD, Ketz N (2011) Complementary learning systems. Cogn Sci. 2011 Dec. doi: 10. 1111/j. 1551-6709. 2011. 01214. x. [Epub ahead of print]
72. van Groen T, Wyss JM (1990) Extrinsic projections from area CA1 of the rat hippocampus: olfactory, cortical, subcortical, and bilateral hippocampal formation projections. J Comp Neurol 302: 515-528
73. Cenquizca LA, Swanson LW (2007) Spatial organization of direct hippocampalfield CA1 axonal projections to the rest of the cerebral cortex. Brain Res Rev 56: 1-26
74. Pannasch U et al (2011) Astroglial networks scale synaptic activity and plasticity. Proc Natl Acad Sci USA 108: 8467-8472
75. Tremblay ME, Majewska AK (2011) A role for microglia in synaptic plasticity. Commun Integr Biol 4: 220-222
76. Ben Achour S, Pascual O (2010) Glia: the many ways to modulate synaptic plasticity. Neurochem Int 57: 440-445
77. Bessis A, Bechade C, Bernard D, Roumier A (2007) Microglial control of neuronal death and synaptic properties. Glia 55: 233-238
78. Xiong H et al (2003) Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J Neurosci Res 71: 600-607
79. Vlkolinsky R, Siggins GR, Campbell IL, Krucker T (2004) Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices. J Neuroimmunol 150: 37-47
80. Zhou Y, Tang H, Liu J, Dong J, Xiong H (2011) Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem 116: 406-414
81. Bertollini C, Ragozzino D, Gross C, Limatola C, Eusebi F (2006) Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology 51: 816-821
82. Maggi L et al (2009) LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R). J Neuroimmunol 215: 36-42
83. Piccinin S et al (2010) CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. J Neuroimmunol 224: 85-92
84. Marchionni I et al (2010) Distinctive properties of CXC chemokine receptor 4-expressing Cajal-Retzius cells versus GABAergic interneurons of the postnatal hippocampus. J Physiol 588: 2859-2878
85. Pautassi RM, Myers M, Spear LP, Molina JC, Spear NE (2008) Adolescent but not adult rats exhibit ethanol-mediated appetitive second-order conditioning. Alcohol Clin Exp Res 32: 2016-2027
86. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463
87. Maccaferri G (2011) Modulation of hippocampal stratum lacunosum-moleculare microcircuits. J Physiol 589: 1885-1891
88. Bhattacharyya BJ et al (2008) The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J Neurosci 28: 6720-6730
89. Pujol F, Kitabgi P, Boudin H (2005) The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J Cell Sci 118: 1071-1080
90. Tran PB, Ren D, Veldhouse TJ, Miller RJ (2004) Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J Neurosci Res 76: 20-34
91. Huang D et al (2002) Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. J Neurosci 22: 10633-10642
92. Boztug K et al (2002) Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand. J Immunol 169: 1505-1515
93. Huang D et al (2005) Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB J 19: 761-772
94. Nelson TE, Hao C, Manos J, Ransohoff RM, Gruol DL (2011) Altered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression. Brain Behav Immun 25(Suppl 1): S106-S119
95. Bray JG, Reyes KC, Ransohoff RM, Gruol DL (2011) Synaptic plasticity in the hippocampus shows resistance to acute ethanol exposure in transgenic mice with astrocyte-targeted enhanced CCL2 expression. Alcohol Clin Exp Res 35(Suppl): 61A
96. Przewlocki R et al (1999) Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons. J Neurosci 19: 9705-9715
97. Nelson TE, Gruol DL (2004) The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons. J Neuroimmunol 156: 74-87
98. Liu Z et al (2003) Frequency modulation of synchronized Ca2+ spikes in cultured hippocampal networks through G-protein-coupled receptors. J Neurosci 23: 4156-4163
99. Cho JS, Gruol DL (2008) The chemokine CCL2 activates p38 mitogen-activated protein kinase pathway in cultured rat hippocampal cells, J Neuroimmunol 199: 94-103
100. Cho J, Nelson TE, Bajova H, Gruol DL (2009) Chronic CXCL10 alters neuronal properties in rat hippocampal culture. J Neuroimmunol 207: 92-100
101. Kuijpers M, van Gassen KL, de Graan PN, Gruol D (2010) Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures. J Neuroimmunol 229: 73-80
102. He J, Crews FT (2008) Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol 210: 349-358
103. Qin L et al (2008) Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 5: 10
104. Flora G et al (2005) Proinflammatory synergism of ethanol and HIV-1 Tat protein in brain tissue. Exp Neurol 191: 2-12
105. Blednov YA et al (2005) Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol. Behav Brain Res 165: 110-125
106. Breese GR et al (2008) Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology 33: 867-876
107. Zou J, Crews F (2010) Induction of innate immune gene expression cascades in brain slice cultures by ethanol: key role of NF-kappaB and proinflammatory cytokines. Alcohol Clin Exp Res 34: 777-789
108. Boyadjieva NI, Sarkar DK (2010) Role of microglia in ethanol's apoptotic action on hypothalamic neuronal cells in primary cultures. Alcohol Clin Exp Res 34: 1835-1842
109. Gonzalez A, Salido GM (2009) Ethanol alters the physiology of neuron-glia communication. Int Rev Neurobiol 88: 167-198
110. Ward RJ et al (2009) Neuro-inflammation induced in the hippocampus of 'binge drinking' rats may be mediated by elevated extracellular glutamate content. J Neurochem 111: 1119-1128
111. Tomas M, Marin P, Megias L, Egea G, Renau-Piqueras J (2005) Ethanol perturbs the secretory pathway in astrocytes. Neurobiol Dis 20: 773-784
112. Catlin MC, Guizzetti M, Costa LG (1999) Effects of ethanol on calcium homeostasis in the nervous system: implications for astrocytes. Mol Neurobiol 19: 1-24
113. Satriotomo I et al (2000) Short-term ethanol exposure alters calbindin D28k and glialfibrillary acidic protein immunoreactivity in hippocampus of mice. Brain Res 879: 55-64
114. Gonzalez A, Pariente JA, Salido GM (2007) Ethanol stimulates ROS generation by mitochondria through Ca2+ mobilization and increases GFAP content in rat hippocampal astrocytes. Brain Res 1178: 28-37
115. Franke H (1995) Influence of chronic alcohol treatment on the GFAP-immunoreactivity in astrocytes of the hippocampus in rats. Acta Histochem 97: 263-271
116. McClain JA et al (2011) Adolescent binge alcohol exposure induces long-lasting partial activation of microglia. Brain Behav Immun 25(Suppl 1): S120-S128
117. Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638-647
118. Okun E, Griffioen KJ, Mattson MP (2011) Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 34: 269-281
119. Carty M, Bowie AG (2011) Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem Pharmacol 81: 825-837
120. Blanco AM, Valles SL, Pascual M, Guerri C (2005) Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J Immunol 175: 6893-6899
121. Fernandez-Lizarbe S, Pascual M, Guerri C (2009) Critical role of TLR4 response in the activation of microglia induced by ethanol. J Immunol 183: 4733-4744
122. Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C (2010) Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J Neurosci 30: 8285-8295
123. Pascual M, Balino P, Alfonso-Loeches S, Aragon CM, Guerri C (2011) Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain Behav Immun 25(Suppl 1): S80-S91
124. White AM, Matthews DB, Best PJ (2000) Ethanol, memory, and hippocampal function: a review of recentfindings. Hippocampus 10: 88-93
125. Chin VS, Van Skike CE, Matthews DB (2010) Effects of ethanol on hippocampal function during adolescence: a look at the past and thoughts on the future. Alcohol 44: 3-14
126. Weiner JL, Valenzuela CF (2006) Ethanol modulation of GABAergic transmission: the view from the slice. Pharmacol Ther 111: 533-554
127. Kumar S et al (2009) The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) 205: 529-564
128. Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49: 173-184
129. Barclay JW et al (2010) Presynaptic targets for acute ethanol sensitivity. Biochem Soc Trans 38: 172-176
130. Lovinger DM, Roberto M (2013) Synaptic effects induced by alcohol. Curr Top Behav Neurosci 13: 31-86
131. Bloom FE, Siggins GR (1987) Electrophysiological action of ethanol at the cellular level. Alcohol 4: 331-337
132. Newlin SA, Mancillas-Trevino J, Bloom FE (1981) Ethanol causes increases in excitation and inhibition in area CA3 of the dorsal hippocampus. Brain Res 209: 113-128
133. Wiesner JB, Henriksen SJ, Bloom FE (1987) Ethanol enhances recurrent inhibition in the dentate gyrus of the hippocampus. Neurosci Lett 79: 169-173
134. Lovinger DM, White G, Weight FF (1990) NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat. J Neurosci 10: 1372-1379
135. Lovinger DM, White G, Weight FF (1990) Ethanol inhibition of neuronal glutamate receptor function. Ann Med 22: 247-252
136. Wu PH, Coultrap S, Browning MD, Proctor WR (2010) Correlated changes in NMDA receptor phosphorylation, functional activity, and sedation by chronic ethanol consumption. J Neurochem 115: 1112-1122
137. Proctor WR, Diao L, Freund RK, Browning MD, Wu PH (2006) Synaptic GABAergic and glutamatergic mechanisms underlying alcohol sensitivity in mouse hippocampal neurons. J Physiol 575: 145-159
138. Roh MS, Cui FJ, Kim HK, Kang UG (2011) Regulation of NMDA receptor subunits after acute ethanol treatment in rat brain. Alcohol Alcohol 46: 672-679
139. Hicklin TR et al (2011) Alcohol inhibition of the NMDA receptor function, long-term potentiation, and fear learning requires striatal-enriched protein tyrosine phosphatase. Proc Natl Acad Sci USA 108: 6650-6655
140. Nagy J (2004) The NR2B subtype of NMDA receptor: a potential target for the treatment of alcohol dependence. Curr Drug Targets CNS Neurol Disord 3: 169-179
141. Yaka R, Tang KC, Camarini R, Janak PH, Ron D (2003) Fyn kinase and NR2B-containing NMDA receptors regulate acute ethanol sensitivity but not ethanol intake or conditioned reward. Alcohol Clin Exp Res 27: 1736-1742
142. Miyakawa T et al (1997) Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function. Science 278: 698-701
143. Hendricson AW, Sibbald JR, Morrisett RA (2004) Ethanol alters the frequency, amplitude, and decay kinetics of Sr2+-supported, asynchronous NMDAR mEPSCs in rat hippocampal slices. J Neurophysiol 91: 2568-2577
144. Swartzwelder HS, Wilson WA, Tayyeb MI (1995) Differential sensitivity of NMDA receptormediated synaptic potentials to ethanol in immature versus mature hippocampus. Alcohol Clin Exp Res 19: 320-323
145. Criswell HE, Ming Z, Griffith BL, Breese GR (2003) Comparison of effect of ethanol on N-methyl-d -aspartate-and GABA-gated currents from acutely dissociated neurons: absence of regional differences in sensitivity to ethanol. J Pharmacol Exp Ther 304: 192-199
146. Gordey M, Mekmanee L, Mody I (2001) Altered effects of ethanol in NR2A(DeltaC/DeltaC) mice expressing C-terminally truncated NR2A subunit of NMDA receptor. Neuroscience 105: 987-997
147. Weiner JL, Dunwiddie TV, Valenzuela CF (1999) Ethanol inhibition of synaptically evoked kainate responses in rat hippocampal CA3 pyramidal neurons. Mol Pharmacol 56: 85-90
148. Martin D, Tayyeb MI, Swartzwelder HS (1995) Ethanol inhibition of AMPA and kainate receptor-mediated depolarizations of hippocampal area CA1. Alcohol Clin Exp Res 19: 1312-1316
149. Moykkynen T, Korpi ER, Lovinger DM (2003) Ethanol inhibits alpha-amino-3-hydyroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor function in central nervous system neurons by stabilizing desensitization. J Pharmacol Exp Ther 306: 546-555
150. Carta M, Ariwodola OJ, Weiner JL, Valenzuela CF (2003) Alcohol potently inhibits the kainate receptor-dependent excitatory drive of hippocampal interneurons. Proc Natl Acad Sci USA 100: 6813-6818
151. Crowder TL, Ariwodola OJ, Weiner JL (2002) Ethanol antagonizes kainate receptor-mediated inhibition of evoked GABA(A) inhibitory postsynaptic currents in the rat hippocampal CA1 region. J Pharmacol Exp Ther 303: 937-944
152. Weiner JL, Zhang L, Carlen PL (1994) Potentiation of GABAA-mediated synaptic current by ethanol in hippocampal CA1 neurons: possible role of protein kinase C. J Pharmacol Exp Ther 268: 1388-1395
153. Wan FJ, Berton F, Madamba SG, Francesconi W, Siggins GR (1996) Low ethanol concentrations enhance GABAergic inhibitory postsynaptic potentials in hippocampal pyramidal neurons only after block of GABAB receptors. Proc Natl Acad Sci USA 93: 5049-5054
154. Ariwodola OJ, Weiner JL (2004) Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. J Neurosci 24: 10679-10686
155. Weiner JL, Valenzuela CF, Watson PL, Frazier CJ, Dunwiddie TV (1997) Elevation of basal protein kinase C activity increases ethanol sensitivity of GABA(A) receptors in rat hippocampal CA1 pyramidal neurons. J Neurochem 68: 1949-1959
156. Nelson TE, Ur CL, Gruol DL (2005) Chronic intermittent ethanol exposure enhances NMDAreceptor-mediated synaptic responses and NMDA receptor expression in hippocampal CA1 region. Brain Res 1048: 69-79
157. Fujii S, Yamazaki Y, Sugihara T, Wakabayashi I (2008) Acute and chronic ethanol exposure differentially affect induction of hippocampal LTP. Brain Res 1211: 13-21
158. Whittington MA, Lambert JD, Little HJ (1995) Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability. Alcohol Alcohol 30: 105-114
159. Thomas MP, Monaghan DT, Morrisett RA (1998) Evidence for a causative role of N-methyld -aspartate receptors in an in vitro model of alcohol withdrawal hyperexcitability. J Pharmacol Exp Ther 287: 87-97
160. Molleman A, Little HJ (1995) Increases in non-N-methyl-d -aspartate glutamatergic transmission, but no change in gamma-aminobutyric acidB transmission, in CA1 neurons during withdrawal from in vivo chronic ethanol treatment. J Pharmacol Exp Ther 274: 1035-1041
161. Gulya K, Grant KA, Valverius P, Hoffman PL, Tabakoff B (1991) Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res 547: 129-134
162. Hendricson AW et al (2007) Aberrant synaptic activation of N-methyl-d -aspartate receptors underlies ethanol withdrawal hyperexcitability. J Pharmacol Exp Ther 321: 60-72
163. Mulholland PJ, Becker HC, Woodward JJ, Chandler LJ (2011) Small conductance calciumactivated potassium type 2 channels regulate alcohol-associated plasticity of glutamatergic synapses. Biol Psychiatry 69: 625-632
164. Nagy J (2008) Alcohol related changes in regulation of NMDA receptor functions. Curr Neuropharmacol 6: 39-54
165. Rudolph JG, Walker DW, Iimuro Y, Thurman RG, Crews FT (1997) NMDA receptor binding in adult rat brain after several chronic ethanol treatment protocols. Alcohol Clin Exp Res 21: 1508-1519
166. Fleming RL, Manis PB, Morrow AL (2009) The effects of acute and chronic ethanol exposure on presynaptic and postsynaptic gamma-aminobutyric acid (GABA) neurotransmission in cultured cortical and hippocampal neurons. Alcohol 43: 603-618
167. Liang J et al (2006) Chronic intermittent ethanol-induced switch of ethanol actions from extrasynaptic to synaptic hippocampal GABAA receptors. J Neurosci 26: 1749-1758
168. Olsen RW, Liang J, Cagetti E, Spigelman I (2005) Plasticity of GABAA receptors in brains of rats treated with chronic intermittent ethanol. Neurochem Res 30: 1579-1588
169. Kang M, Spigelman I, Sapp DW, Olsen RW (1996) Persistent reduction of GABA(A) receptor-mediated inhibition in rat hippocampus after chronic intermittent ethanol treatment. Brain Res 709: 221-228
170. Rogers CJ, Hunter BE (1992) Chronic ethanol treatment reduces inhibition in CA1 of the rat hippocampus. Brain Res Bull 28: 587-592
171. Cagetti E, Liang J, Spigelman I, Olsen RW (2003) Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors. Mol Pharmacol 63: 53-64
172. Sinclair JG, Lo GF (1986) Ethanol blocks tetanic and calcium-induced long-term potentiation in the hippocampal slice. Gen Pharmacol 17: 231-233
173. Puglia MP, Valenzuela CF (2010) Ethanol acutely inhibits ionotropic glutamate receptormediated responses and long-term potentiation in the developing CA1 hippocampus. Alcohol Clin Exp Res 34: 594-606
174. Blitzer RD, Gil O, Landau EM (1990) Long-term potentiation in rat hippocampus is inhibited by low concentrations of ethanol. Brain Res 537: 203-208
175. Izumi Y, Nagashima K, Murayama K, Zorumski CF (2005) Acute effects of ethanol on hippocampal long-term potentiation and long-term depression are mediated by different mechanisms. Neuroscience 136: 509-517
176. Tokuda K, Zorumski CF, Izumi Y (2007) Modulation of hippocampal long-term potentiation by slow increases in ethanol concentration. Neuroscience 146: 340-349
177. Mulkeen D, Anwyl R, Rowan MJ (1987) Enhancement of long-term potentiation by the calcium channel agonist Bayer K8644 in CA1 of the rat hippocampus in vitro. Neurosci Lett 80: 351-355
178. Sugiura M, Shoyama Y, Saito H, Abe K (1995) The effects of ethanol and crocin on the induction of long-term potentiation in the CA1 region of rat hippocampal slices. Jpn J Pharmacol 67: 395-397
179. Swartzwelder HS, Wilson WA, Tayyeb MI (1995) Age-dependent inhibition of long-term potentiation by ethanol in immature versus mature hippocampus. Alcohol Clin Exp Res 19: 1480-1485
180. Schummers J, Bentz S, Browning MD (1997) Ethanol's inhibition of LTP may not be mediated solely via direct effects on the NMDA receptor. Alcohol Clin Exp Res 21: 404-408
181. Morrisett RA, Swartzwelder HS (1993) Attenuation of hippocampal long-term potentiation by ethanol: a patch-clamp analysis of glutamatergic and GABAergic mechanisms. J Neurosci 13: 2264-2272
182. Hendricson AW, Miao CL, Lippmann MJ, Morrisett RA (2002) Ifenprodil and ethanol enhance NMDA receptor-dependent long-term depression. J Pharmacol Exp Ther 301: 938-944
183. Durand D, Carlen PL (1984) Impairment of long-term potentiation in rat hippocampus following chronic ethanol treatment. Brain Res 308: 325-332
184. Roberto M, Nelson TE, Ur CL, Gruol DL (2002) Long-term potentiation in the rat hippocampus is reversibly depressed by chronic intermittent ethanol exposure. J Neurophysiol 87: 2385-2397
185. Tremwel MF, Hunter BE (1994) Effects of chronic ethanol ingestion on long-term potentiation remain even after a prolonged recovery from ethanol exposure. Synapse 17: 141-148
186. McCool BA (2011) Ethanol modulation of synaptic plasticity. Neuropharmacology 61: 1097-1108
187. Chandler LJ, Sutton G (2005) Acute ethanol inhibits extracellular signal-regulated kinase, protein kinase B, and adenosine 3′: 5′ -cyclic monophosphate response element binding protein activity in an age-and brain region-specific manner. Alcohol Clin Exp Res 29: 672-682
188. Asyyed A, Storm D, Diamond I (2006) Ethanol activates cAMP response element-mediated gene expression in select regions of the mouse brain. Brain Res 1106: 63-71
189. Kumar S, Lane BM, Morrow AL (2006) Differential effects of systemic ethanol administration on protein kinase cepsilon, gamma, and beta isoform expression, membrane translocation, and target phosphorylation: reversal by chronic ethanol exposure. J Pharmacol Exp Ther 319: 1366-1375
190. Wilkie MB et al (2007) Acute ethanol administration rapidly increases phosphorylation of conventional protein kinase C in specific mammalian brain regions in vivo. Alcohol Clin Exp Res 31: 1259-1267
191. Proctor WR et al (2003) Ethanol differentially enhances hippocampal GABA A receptormediated responses in protein kinase C gamma (PKC gamma) and PKC epsilon null mice. J Pharmacol Exp Ther 305: 264-270
192. Choi DS et al (2008) Protein kinase Cdelta regulates ethanol intoxication and enhancement of GABA-stimulated tonic current. J Neurosci 28: 11890-11899
193. Yaka R, Phamluong K, Ron D (2003) Scaffolding of Fyn kinase to the NMDA receptor determines brain region sensitivity to ethanol. J Neurosci 23: 3623-3632
194. Roberto M et al (2003) The transient depression of hippocampal CA1 LTP induced by chronic intermittent ethanol exposure is associated with an inhibition of the MAP kinase pathway. Eur J Neurosci 17: 1646-1654
195. Sanna PP, Simpson C, Lutjens R, Koob G (2002) ERK regulation in chronic ethanol exposure and withdrawal. Brain Res 948: 186-191
196. Abraham WC, Williams JM (2008) LTP maintenance and its protein synthesis-dependence. Neurobiol Learn Mem 89: 260-268
197. Kemp A, Manahan-Vaughan D (2007) Hippocampal long-term depression: master or minion in declarative memory processes. Trends Neurosci 30: 111-118
198. Lee HK (2006) AMPA receptor phosphorylation in synaptic plasticity: insights from knockin mice. In: Kittler JT, Moss SJ (eds) The dynamic synapse: molecular methods in ionotropic receptor biology, Chap. CRC Press, Boca Raton
199. Erickson MA, Maramara LA, Lisman J (2010) A single brief burst induces GluR1-dependent associative short-term potentiation: a potential mechanism for short-term memory. J Cogn Neurosci 22: 2530-2540
200. Silva AJ et al (1996) Impaired learning in mice with abnormal short-lived plasticity. Curr Biol 6: 1509-1518
201. Schulz PE, Fitzgibbons JC (1997) Differing mechanisms of expression for short-and long-term potentiation. J Neurophysiol 78: 321-334
202. Lauri SE et al (2007) Presynaptic mechanisms involved in the expression of STP and LTP at CA1 synapses in the hippocampus. Neuropharmacology 52: 1-11
203. Zucker RS, Regehr WG (2002) Short-term synaptic plasticity. Annu Rev Physiol 64: 355-405
204. Miyamoto E (2006) Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus. J Pharmacol Sci 100: 433-442
205. Nguyen PV, Woo NH (2003) Regulation of hippocampal synaptic plasticity by cyclic AMPdependent protein kinases. Prog Neurobiol 71: 401-437
206. Malenka RC et al (1989) An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature 340: 554-557
207. Waltereit R, Weller M (2003) Signaling from cAMP/PKA to MAPK and synaptic plasticity. Mol Neurobiol 27: 99-106
208. English JD, Sweatt JD (1997) A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem 272: 19103-19106
209. Bolshakov VY, Carboni L, Cobb MH, Siegelbaum SA, Belardetti F (2000) Dual MAP kinase pathways mediate opposing forms of long-term plasticity at CA3-CA1 synapses. Nat Neurosci 3: 1107-1112
210. Butler MP, O'Connor JJ, Moynagh PN (2004) Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 124: 319-326
211. Kelly A et al (2003) Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus. J Biol Chem 278: 19453-19462
212. Josselyn SA, Nguyen PV (2005) CREB, synapses and memory disorders: past progress and future challenges. Curr Drug Targets CNS Neurol Disord 4: 481-497